Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma.
Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G. Palomba G, et al. Among authors: baldino g. Oncol Lett. 2016 Aug;12(2):1415-1421. doi: 10.3892/ol.2016.4798. Epub 2016 Jun 29. Oncol Lett. 2016. PMID: 27446446 Free PMC article.
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
Palomba G, Doneddu V, Cossu A, Paliogiannis P, Manca A, Casula M, Colombino M, Lanzillo A, Defraia E, Pazzola A, Sanna G, Putzu C, Ortu S, Scartozzi M, Ionta MT, Baldino G, Sarobba G, Capelli F, Sedda T, Virdis L, Barca M, Gramignano G, Budroni M, Tanda F, Palmieri G. Palomba G, et al. Among authors: baldino g. J Transl Med. 2016 Oct 13;14(1):292. doi: 10.1186/s12967-016-1053-z. J Transl Med. 2016. PMID: 27737711 Free PMC article.
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia.
Palomba G, Colombino M, Contu A, Massidda B, Baldino G, Pazzola A, Ionta M, Capelli F, Trova V, Sedda T, Sanna G, Tanda F, Budroni M; Sardinian Translational Oncology Group (STOG); Palmieri G, Cossu A, Contu M, Cuccu A, Farris A, Macciò A, Mameli G, Olmeo N, Ortu S, Petretto E, Pusceddu V, Virdis L. Palomba G, et al. Among authors: baldino g. J Transl Med. 2012 Aug 29;10:178. doi: 10.1186/1479-5876-10-178. J Transl Med. 2012. PMID: 22931052 Free PMC article.
Omniflow® II biosynthetic graft offers acceptable early and mid-term outcomes in redo surgery in patients with critical limb-threatening ischemia with no available autologous vein material.
Troisi N, Socrate AM, Vigliotti G, Dorrucci V, Benedetto F, Frigatti P, Michelagnoli S, Berchiolli R; BIOPRO Registry Collaborative Group. Troisi N, et al. Int Angiol. 2024 Apr;43(2):255-261. doi: 10.23736/S0392-9590.24.05152-6. Epub 2024 Feb 12. Int Angiol. 2024. PMID: 38345547
49 results